Mee-Hye Park

Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea.

Myung Ah Lee, E. Lee, S. Shin, 2012, Clinical therapeutics.

Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes

L. Peyrin-Biroulet, F. Rieder, V. Jairath, 2023, Journal of Crohn's & colitis.